Generate Biomedicines annual operating margin
2024
2025
Generate Biomedicines Operating Margin Growth & History (GENB)
Generate Biomedicines's operating margin was −737.04% for fiscal 2025.
View full Generate Biomedicines company overviewGenerate Biomedicines annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −737.04% | +225.56 pp |
| 2024 | 2024-12-31 | −962.60% | — |
Generate Biomedicines quarterly operating margin
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,134.21% | −540.43 pp |
| Q1 2026 | 2026-03-31 | −887.49% | −341.40 pp |
| Q2 2025 | 2025-06-30 | −593.78% | — |
| Q1 2025 | 2025-03-31 | −546.09% | — |
Generate Biomedicines operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Generate Biomedicines's operating margin increased from −962.60% to −737.04%, a change of +225.56 percentage points. The latest reported quarter, Q2 2026, shows −1,134.21%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Generate Biomedicines source filings ↗